Abstract
Previous chapters and indeed most of the existing literature on the welfare effects of new products in developing countries are based on a form of analysis (developed primarily by Lancaster) that focuses on the specific characteristics embodied in those products.1 Those combinations of characteristics are then evaluated from the point of view of their appropriateness to household groups differentiated, most frequently, by levels of income. Because they are mainly produced in developed countries, new products, so the argument usually runs, contain a high proportion of ‘high-income’ characteristics that make them unconducive to the satisfaction of basic needs in developing countries. Or, put another way, the conclusion is typically that new products tend to confer their benefits disproportionately on rich rather than poor consumers in developing countries.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
K. Bennett, P. Tugwell, D. Sackett and B. Haynes (1990). ‘Relative Risks, Benefits, and Costs of Intervention’, in K. Warren and A. Mahmoud (eds), Tropical and Geographical Medicine, 2nd edn, McGraw-Hill.
R. Blum (1981). ‘Factors Affecting Individual Use of Medicines’, in R. Blum et al. (eds), Pharmaceuticals and Health Policy, Holmes and Meier.
G. A. Cohen (1993). ‘Equality of What? On Welfare, Goods and Capabilities’ in M. Nussbaum and A. Sen (eds), The Quality of Life, Clarendon Press.
G. Cowan and B. Heap (1993). Clinical Tropical Medicine, Chapman and Hall.
T. Greenhalgh (1987). ‘Drug Prescription and Self-Medication in India: An Exploratory Survey’, Social Science Medicine, 25 (3).
A. Hardon (1987). ‘The Use of Modern Pharmaceuticals in a Filipino Village: Doctor’s Prescription and Self Medication’, Social Science Medicine, 25 (3).
G. Helleiner (1975). ‘The Role of Multinational Corporations in the LDC’s Trade in Technology’, World Development, 3 (4).
H. Hogerzeil (1986). ‘Use of Essential Drugs in Rural Ghana’, International Journal of Health Services, 16 (3).
J. James and F. Stewart (1981). ‘New Products: A Discussion of the Welfare Effects of the Introduction of New Products in Developing Countries’, Oxford Economic Papers.
D. Jelliffe and E. Jelliffe (1978). Human Milk in the Modern World, Oxford University Press.
R. Jenkins (1988). ‘Transnational Corporations and Third World Consumption: Implications of Competitive Strategies’, World Development, 16 (11).
K. Krishnaswamy, B. Kumar and G. Radhaiah (1985). ‘A Drug Survey-Precepts and Practices’, European Journal of Clinical Pharmacology, 29.
E. Martin (1978). Hazards of Medication, 2nd edn, J. B. Lippincott Co.
M. Muller (1982). The Health of Nations, Faber and Faber.
N. Osifo (1983). ‘Overpromotion of Drugs in International Product Package Inserts’, Tropical Doctor, Jan.
H. Rang, M. Dale and J. Ritter (1995). Pharmacology, Churchill, Livingstone.
A. Schapira (1990). ‘The Resistance of Falciparum Malaria in Africa to 4-Aminoquinolines and Antifolates’, Scandinavian Journal of Infectious Diseases, Supplement 75.
K. Schmidt (1995). ‘Inbred Parasites May Spur Resistance’, Science, 269, 22 Sept.
C. Sekhar, R. Raina and G. Pillai (1981). ‘Some Aspects of Drug Use in Ethiopia’, Tropical Doctor, July.
A. Sen (1985). Commodities and Capabilities, North-Holland.
M. Silverman and P. Lee (1974). Pills, Profits and Politics, University of California Press.
M. Silverman, P. Lee and M. Lydecker (1982). Prescriptions for Death: the Drugging of the Third World, University of California Press.
R. Snyder, H. Mofenson and J. Greensher (1973). ‘Toxicity from Lomotil’, Clinical Pediatrics, January.
F. Stewart (1977). Technology and Underdevelopment, Macmillan.
D. Weatherall (1990). ‘Common Genetic Disorders in the Tropics’, in K. Warren and A. Mahmoud (eds), Tropical and Geographical Medicine, 2nd edn, McGraw-Hill.
I. Wickramasekera (1985). ‘A Conditional Response Model of the Placebo Effect: Predictions from the Model’ in L. White, B. Tursky and G. Schwartz (eds), Placebo: Theory, Research and Mechanisms, Guilford Press.
I. Wolffers (1987). ‘Drug Information and Sale Practices in Some Pharmacies of Colombo, Sri Lanka’, Social Science Medicine, 25 (3).
Author information
Authors and Affiliations
Copyright information
© 2000 Jeffrey James
About this chapter
Cite this chapter
James, J. (2000). From Global Products to Individual Functionings: Medicinal Drugs in Developing Countries. In: Consumption, Globalization and Development. Palgrave Macmillan, London. https://doi.org/10.1057/9780230510951_4
Download citation
DOI: https://doi.org/10.1057/9780230510951_4
Publisher Name: Palgrave Macmillan, London
Print ISBN: 978-1-349-41571-7
Online ISBN: 978-0-230-51095-1
eBook Packages: Palgrave Economics & Finance CollectionEconomics and Finance (R0)